This will lead to an increase in von Willebrand Factor (VWF) levels via disruption to the endothelial cell lining [4]. Numerous observational studies have described a link between COVID-19 infection and increased susceptibility to thrombosis via coagulopathy and disseminated intravascular coagulation (DIC) [5]. This evidence concerns the gene VWF and blood coagulation disease.